Table 1.
Main characteristics of the sample
| PES Group, n (%) | No PES Group, n (%) | P | |
|---|---|---|---|
| Number of eyes/patients (n) | 106 (120) | 487 (561) | |
| Males | 52 (50.94) | 201 (39.96) | 0.0373* |
| Age (mean±SD) | 77.87±5.57 | 75.75±6.89 | 0.0031** |
| Maximum mydriasis (mean±SD) | 7.24±0.88 | 7.80±0.88 | 0.0000** |
| Nuclear hardness ≥3 | 34 (30.36) | 150 (32.08) | 0.7288 |
| Anterior chamber depth <3 (van Herick grading) | 16 (15.09) | 72 (14.31) | 0.8355 |
| Glaucoma | 39 (36.79) | 94 (18.69) | 0.0000** |
| Alpha agonists | 22 (20.75) | 104 (20.68) | 0.9855 |
| Antiplatelet use | 36 (33.96) | 128 (25.45) | 0.0725 |
| Anticoagulant use | 27 (25.47) | 97 (19.28) | 0.1510 |
| High myopia | 16 (15.09) | 74 (14.71) | 0.9196 |
| Steroid use | 23 (21.70) | 89 (17.69) | 0.3335 |
*Significant at 0.05, **Significant at 0.01. PES: Pseudoexfoliation, SD: Standard deviation